Spruce Biosciences raises $69M through public offering at $50/share

Filed April 22, 2026 · Period ending April 20, 2026 · ~1 min read

Key Changes

• high

  Company sold 1.15M common shares at $50/share plus 50K pre-funded warrants at $49.99/share; underwriters exercised full overallotment option for 180K additional shares, bringing gross proceeds to ~$69M before fees.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• medium

  Pre-funded warrants are immediately exercisable at $0.01/share with ownership caps at 4.99% (adjustable to 9.99% with 61 days' notice) to prevent concentration.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• medium

  Offering priced April 20, 2026 and expected to close April 22, 2026 under shelf registration declared effective November 26, 2025.

  Item 8.01 — Other Events verify on EDGAR →